ArticleFrontiers in oncology2025
Range quality assurance measurements for clinical and FLASH proton beam therapy using the quality assurance range calorimeter.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This work demonstrated the design and performance of a full-sized clinical prototype of the Quality Assurance Range Calorimeter (QuARC): a segmented large-volume scintillator-based detector for fast, accurate proton range quality assurance (QA) measurements. Materials & methods: The detector used 128 scintillator sheets of size 105 × 105 × 3 mm arranged into 4 modules of 32 sheets, where each sheet was directly coupled to a photodiode. Fast analogue-to-digital conversion facilitated measurement of scintillator sheet light output to 20-bit precision at 6 kHz, with a dynamic range of up to 350 pC. Results: Proton range measurements with the full-size detector were performed at the proton therapy research facility based at The Christie at clinical dose rates, corresponding to ∼1 nA nozzle current, where the range accuracy of the QuARC was found to be within 0.4 mm of facility reference across the full clinical energy range. The QuARC successfully performed range measurements of the 245 MeV beam at FLASH dose rate (∼50 nA nozzle current), where the fitted range agreed with the clinical current measurement to 0.3 mm. Preliminary results show charge linearity of the detector to be within 3%. Conclusions: The QuARC has been shown to be a promising candidate for fast, accurate range QA at conventional clinical dose rates and thanks to its high precision and dynamic range, has been shown to also be viable at FLASH dose rates. Future work will investigate improving the accuracy and stability of the calibration process by optimising the scintillator sheet light output and mechanical setup.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.